,

Clinicopathologic significance of expression of nuclear factor kappa B and its target gene products in gastric cancer patients

,

A phase II trial of erlotinib in combination with gemcitabine and cisplatin for unresectable pancreatic cancer

,

Systemic inflammatory response in predicting survival in patients with operable colorectal cancer

,

Phase II study of vinorelbine plus trastuzumab in HER-2 overexpressing metastatic breast cancer pretreated with anthracyclines and taxanes

,

Validation of National Comprehensive Cancer Network(NCCN) guideline for cancer pain control